Shares of AstraZeneca Plc were gaining around 4 percent in London trading as well as around 5 percent in pre-market activity on Nasdaq after the British drug major reported Friday significantly higher profit for its second quarter. Top line beat market estimates. Further, the company maintained its outlook for fiscal 2023, expecting growth. In addition, AstraZeneca noted that its Rare Disease ...
from RTT - Top Story https://ift.tt/qe1gcnl
via IFTTT
from RTT - Top Story https://ift.tt/qe1gcnl
via IFTTT
Comments
Post a Comment